Bedminster-based Aerie Pharmaceuticals Inc. announced Wednesday the closing of its initial public offering. The company raised approximately $68.4 million, after underwriting discounts and commissions and estimated offering expenses.

According to the announcement, the company offered 7,728,000 shares of its common stock, including 1,008,000 shares of common stock issued upon the exercise in full by the underwriters of their option to purchase additional shares to cover over-allotments, at a price of $10.00 per share. The raise is slightly higher than the company expected in its pricing announcement last week.